Qualigen Therapeutics, Inc. Common Stock (QLGN) Income Statement (2020 - 2025)
Income Statement report data from Jun 30, 2020 to Sep 30, 2025 for Qualigen Therapeutics, Inc. Common Stock (QLGN).
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.43M (+98.61%) | 720K (-51.35%) | 1.48M (+27.59%) | 1.16M (+3.57%) | 1.12M (-41.05%) | 1.90M (+126.19%) | 840K (-6.67%) | 900K |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10M (+32.53%) | 830K (-31.97%) | 1.22M (+23.23%) | 990K (+7.61%) | 920K (-23.33%) | 1.20M (+30.43%) | 920K (+13.58%) | 810K |
Costof Goods And Services Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10M (+32.53%) | 830K (-31.97%) | 1.22M (+23.23%) | 990K (+7.61%) | 920K (-23.33%) | 1.20M (+30.43%) | 920K (+13.58%) | 810K |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 330K | -110.00K | 260K (+62.50%) | 160K (-20.00%) | 200K (-71.43%) | 700K | -80.00K | 100K |
Operating Expenses | |||||||||||||||||||||
Research And Development | 110K (+450.00%) | 20K (-33.33%) | 30K | -40.00K | 120K (-84.00%) | 750K (+108.33%) | 360K (-72.52%) | 1.31M (-9.03%) | 1.44M (+23.08%) | 1.17M (-8.59%) | 1.28M (+47.13%) | 870K (-6.45%) | 930K (-38.41%) | 1.51M (-18.82%) | 1.86M (+14.11%) | 1.63M (-21.63%) | 2.08M (-53.88%) | 4.51M (+28.86%) | 3.50M (+302.30%) | 870K (+45.00%) | 600K |
Selling General And Administrative | 1.89M (+35.97%) | 1.39M (-44.18%) | 2.49M (+144.12%) | 1.02M (-11.30%) | 1.15M (+16.16%) | 990K (-6.60%) | 1.06M (+10.42%) | 960K (-28.36%) | 1.34M (-44.86%) | 2.43M (+77.37%) | 1.37M (-46.69%) | 2.57M (+1.18%) | 2.54M (-14.48%) | 2.97M (-2.30%) | 3.04M (-7.32%) | 3.28M (+13.49%) | 2.89M (-6.47%) | 3.09M (+2.66%) | 3.01M (+9.06%) | 2.76M (+33.33%) | 2.07M |
Operating Expenses | 1.43M (-14.88%) | 1.68M (-38.24%) | 2.72M (+104.51%) | 1.33M (+4.72%) | 1.27M (-27.01%) | 1.74M (+22.54%) | 1.42M (-37.44%) | 2.27M (-18.35%) | 2.78M (-22.78%) | 3.60M (+35.85%) | 2.65M (-22.97%) | 3.44M (-0.86%) | 3.47M (-22.37%) | 4.47M (-8.78%) | 4.90M (-0.20%) | 4.91M (-1.21%) | 4.97M (-34.61%) | 7.60M (+16.74%) | 6.51M (+79.34%) | 3.63M (+35.96%) | 2.67M |
Operating Income | |||||||||||||||||||||
Operating Income | -1.43M (-14.88%) | -1.68M (-38.24%) | -2.72M (+104.51%) | -1.33M (+4.72%) | -1.27M (-27.01%) | -1.74M (+22.54%) | -1.42M (-37.44%) | -2.27M (-18.35%) | -2.78M (-22.78%) | -3.60M (+35.85%) | -2.65M (-22.97%) | -3.44M (-0.86%) | -3.47M (-16.18%) | -4.14M (-17.37%) | -5.01M (+7.74%) | -4.65M (-3.33%) | -4.81M (-34.91%) | -7.39M (+27.19%) | -5.81M (+56.18%) | -3.72M (+44.75%) | -2.57M |
EBITDA | -1.43M (-14.88%) | -1.68M (-38.24%) | -2.72M (+104.51%) | -1.33M (+4.72%) | -1.27M (-27.01%) | -1.74M (+22.54%) | -1.42M (-37.44%) | -2.27M (-18.35%) | -2.78M (-22.78%) | -3.60M (+35.85%) | -2.65M (-22.74%) | -3.43M (-5.77%) | -3.64M (-10.12%) | -4.05M (-17.68%) | -4.92M (+7.89%) | -4.56M (-3.39%) | -4.72M (-35.43%) | -7.31M (+27.57%) | -5.73M (+55.28%) | -3.69M (+45.28%) | -2.54M |
Other Income / Expenses | |||||||||||||||||||||
Interest Income | 190K (+35.71%) | 140K (+27.27%) | 110K (+37.50%) | 80K (+60.00%) | 50K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | -460.00K (+318.18%) | -110.00K (+57.14%) | -70.00K (-30.00%) | -100.00K (-75.61%) | -410.00K (+57.69%) | -260.00K (+85.71%) | -140.00K (-41.67%) | -240.00K (-35.14%) | -370.00K (-2.63%) | -380.00K (-29.63%) | -540.00K (+980.00%) | -50.00K | - | - | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K | - | -60.00K |
Net Interest Income | 650K (+160.00%) | 250K (+31.58%) | 190K (+5.56%) | 180K (-60.87%) | 460K (+76.92%) | 260K (+85.71%) | 140K (-41.67%) | 240K (-35.14%) | 370K (-2.63%) | 380K (-29.63%) | 540K (+980.00%) | 50K | - | - | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (-50.00%) | -20.00K | - | 60K |
Other Non Operating Income | -350.00K (+775.00%) | -40.00K | 40K (-92.00%) | 500K | -170.00K | 530K | -470.00K | 40K | -90.00K | 450K | -40.00K (-63.64%) | -110.00K | 320K (+3100.00%) | 10K (-98.53%) | 680K (+58.14%) | 430K (-75.57%) | 1.76M (-11.11%) | 1.98M (+260.00%) | 550K | -4.39M (-72.48%) | -15.95M |
Net Income | |||||||||||||||||||||
Income Before Tax | -2.04M (+20.71%) | -1.69M (-36.23%) | -2.65M (+211.76%) | -850.00K (-52.78%) | -1.80M (+21.62%) | -1.48M (-27.09%) | -2.03M (-17.81%) | -2.47M (-23.77%) | -3.24M (-8.22%) | -3.53M (+9.29%) | -3.23M (-10.28%) | -3.60M (+14.65%) | -3.14M (-23.79%) | -4.12M (-4.63%) | -4.32M (+2.37%) | -4.22M (+38.82%) | -3.04M (-43.70%) | -5.40M (+3.05%) | -5.24M (-35.39%) | -8.11M (-56.35%) | -18.58M |
Income Tax Expense | - | - | - | 10K | - | - | - | - | - | - | - | - | - | 10K | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -2.04M (+20.71%) | -1.69M (-36.23%) | -2.65M (+208.14%) | -860.00K (-51.96%) | -1.79M (+13.29%) | -1.58M (-22.17%) | -2.03M (-17.14%) | -2.45M (-33.78%) | -3.70M (+5.41%) | -3.51M (-14.60%) | -4.11M (-51.82%) | -8.53M (+110.10%) | -4.06M (-1.69%) | -4.13M (-4.40%) | -4.32M (+2.37%) | -4.22M (+38.82%) | -3.04M (-43.70%) | -5.40M (+3.05%) | -5.24M (-35.39%) | -8.11M (-56.35%) | -18.58M |
Net Income | -2.04M (+20.71%) | -1.69M (-36.23%) | -2.65M (+208.14%) | -860.00K (-51.96%) | -1.79M (+13.29%) | -1.58M (-22.17%) | -2.03M (-17.14%) | -2.45M (-33.78%) | -3.70M (+5.41%) | -3.51M (-14.60%) | -4.11M (-51.82%) | -8.53M (+110.10%) | -4.06M (-1.69%) | -4.13M (-4.40%) | -4.32M (+2.37%) | -4.22M (+38.82%) | -3.04M (-43.70%) | -5.40M (+3.05%) | -5.24M (-35.39%) | -8.11M (-56.35%) | -18.58M |